Authors
Loading...
Expert commentary demonstrates strong opposition to relaxing conflict of interest policies in medical publishing, highlighting the persistent threat of pharmaceutical industry influence.
Steinbrook et al. (2015) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: